Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

17 trials with published results (15%)

Research Maturity

61 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.2%

6 terminated out of 116 trials

Success Rate

91.0%

+4.5% vs benchmark

Late-Stage Pipeline

10%

12 trials in Phase 3/4

Results Transparency

28%

17 of 61 completed with results

Key Signals

17 with results91% success

Data Visualizations

Phase Distribution

82Total
Not Applicable (29)
Early P 1 (2)
P 1 (16)
P 2 (23)
P 3 (6)
P 4 (6)

Trial Status

Completed61
Unknown25
Recruiting13
Active Not Recruiting6
Terminated6
Withdrawn4

Trial Success Rate

91.0%

Benchmark: 86.5%

Based on 61 completed trials

Clinical Trials (116)

Showing 20 of 20 trials
NCT04669158Phase 1Completed

Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis

NCT03612531Not ApplicableActive Not Recruiting

Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors

NCT07333183Phase 2Recruiting

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

NCT05874492Not ApplicableRecruitingPrimary

Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer

NCT07471542Not ApplicableRecruiting

Copper Supplementation in Cirrhosis

NCT06713200Not ApplicableCompleted

Effectiveness of Percutaneous Electrolysis in Subacute and Early Chronic Medial Gastrocnemius Muscle Injuries

NCT06635850Phase 2Active Not Recruiting

A Study of Mosliciguat in PH-ILD

NCT06494111Phase 2Recruiting

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

NCT05903001Recruiting

Diaphragmatic Function as a Biomarker

NCT06912763Phase 2Recruiting

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

NCT05253287Phase 2Completed

Growth Hormone in Decompensated Liver Cirrhosis

NCT05330923Recruiting

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

NCT05011305Phase 2Completed

Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis

NCT03025074Recruiting

Blood Collection Biorepository for Liver Disease Research

NCT02717650Not ApplicableCompleted

The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis.

NCT06383819Phase 3Completed

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

NCT06561529Not ApplicableRecruitingPrimary

The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region

NCT06749522Active Not RecruitingPrimary

Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And Cirrhosis

NCT04482855Not ApplicableCompleted

Low-Level Laser in Head and Neck Chronic Lymphedema

NCT05570058Phase 2Active Not Recruiting

Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

Scroll to load more

Research Network

Activity Timeline